|Last Price$36.75||Day Change (%)0.99%|
|Open Price$36.40||Day Change ($)0.36|
|Day Range36.36–37.10||52-Week Range28.57–40.72|
As of Fri 10/24/2014 03:16 PM EST | USD
WuXi Congratulates TaiMed Biologics on Receiving Orphan Drug Designation for Ibalizumab from U.S. FDA
WuXi PharmaTech Laboratory Testing Division Expands in U.S. With Acquisition of XenoBiotic Laboratories, Inc.
AZD9291 Shows Durable Clinical Response in Patients with Advanced EGFR Mutation Positive Non-Small Cell Lung Cancer at the ESMO 2014 Congress
The top contract research organizations have opportunities to gain share in a rapidly growing industry.